نتایج جستجو برای: plasma assisted cvd

تعداد نتایج: 496394  

2017
Pei-Ying Zhang

It is well recognized that the elevated plasma level of low-density lipoprotein-cholesterol (LDL-C) is a major risk factor for atherosclerosis and cardiovascular disease (CVD). Deposition of pro-atherogenic LDL-C, on the intima of arterial wall, contributes to plaque formation and atherosclerosis, which further leads to lowered blood flow to vital organs and increased risk of CVD. The most comm...

Journal: :Reports of the National Academy of Sciences of Ukraine 2021

Elevated levels of low-density lipoprotein (LDL-X) cholesterol, apolipoprotein B (ApoB), and especially oxidized LDL in plasma are associated with an increased risk cardiovascular disease (CVD). The aim the study was to determine ApoB oxLDL blood patients diabetes mellitus (DM), CVD COVID-19. were determined using enzyme-linked immunosorbent assay kits (Elabscience, USA). measurements performed...

Journal: :The Journal of pharmacology and experimental therapeutics 1997
J C Rodriguez-Perez A Losada A Anabitarte J Cabrera J Llobet L Palop C Plaza

Antihypertensive drugs have differing effects on renal hemodynamics and morphology. We analyzed whether the use of a new beta adrenoceptor antagonist and vasodilator, carvedilol (CVD), slows the progression of nephrosclerosis and whether the renoprotective effect as well as reduction in cardiac hypertrophy is dependent on the degree of blood pressure reduction. Fifty-four adult male Sprague-Daw...

Journal: :American journal of kidney diseases : the official journal of the National Kidney Foundation 2009
Rohit Bhuriya Suying Li Shu-Cheng Chen Peter A McCullough George L Bakris

BACKGROUND Cardiovascular disease (CVD) is the most common cause of death in patients with chronic kidney disease (CKD). Secondary hyperparathyroidism is common in patients with CKD, and its relationship to CVD is not well defined. This analysis aims to assess whether serum intact parathyroid hormone (PTH) level is an independent risk factor for CVD in patients with CKD stages 3 and 4. METHOD...

Journal: :Journal of Biosciences and Medicines 2023

Hypertension, obesity, smoking, dyslipidemia, and type 2 diabetes (T2D) are the major risk factors for developing cardiovascular diseases (CVD). Recent studies revealed that taxi-motorbike drivers (TMDs) in Cotonou had higher rates of CVD factors, but their impacts on events have rarely been studied. The Framingham score (FRS) is an algorithm considers estimates next 10 years. Our objectives we...

Journal: :Scientific reports 2016
Xiao Hu Mengqi Zeng Yun Long Jun Liu Yixiao Zhu Kaiheng Zou Fan Zhang Lei Fu Jian Wang

We fabricate a nonlinear optical device based on a fiber pigtail cross-section coated with a single-layer graphene grown by chemical vapor deposition (CVD) method. Using the fabricated graphene-assisted nonlinear optical device and employing Nyquist 16-ary quadrature amplitude modulation (16-QAM) signal, we experimentally demonstrate phase conjugated wavelength conversion by degenerate four-wav...

2007
J. Hu Y. K. Chou R. G. Thompson J. Burgess

Diamond coatings made by processes such as chemical vapor deposition (CVD) have been increasingly explored for cutting tools applications, in particular, for machining lightweight high-strength materials. However, most literature to date reported that the wear resistance of CVD diamond tools is still distant to the polycrystalline diamond (PCD) counterparts. Recently, a microwave plasma-assiste...

Journal: :Diabetes care 2004
Peter D Reaven Jerome Sacks

OBJECTIVE To compare lifestyle factors, cardiovascular risk factors, and coronary artery calcium (CAC) and abdominal aortic calcium (AAC) levels in Hispanic and non-Hispanic white (NHW) individuals with type 2 diabetes. RESEARCH DESIGN AND METHODS We recently demonstrated in a small group of nonreferred, healthy, nondiabetic subjects that CAC was reduced in Hispanics compared with NHWs, despi...

2016
Yoshinori Okuda Seitaro Omoto Takehito Taniura Akira Shouzu Shosaku Nomura

BACKGROUND Cardiovascular disease (CVD) is the main cause of death among hemodialysis (HD) patients. The effects of the dipeptidyl peptidase-4 inhibitor teneligliptin on CVD-related biomarkers in patients with type 2 diabetes mellitus (T2DM) receiving HD treatment are poorly understood. To determine whether teneligliptin has anti-CVD properties, we assessed its effects on soluble P-selectin (sP...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید